Assays / Respiratory infections
Respiratory infections
Influenza A/B Fluorescent Antigen Assay
A planned instrument-read flu test, designed to run alongside COVID-19 and RSV tests on the same reader during respiratory season.
At a glance
Targets
Influenza A and influenza B antigens
Sample
Nasal or nasopharyngeal swab
Readout
Instrument-read, logged automatically
Status
Planned
Why it matters
Clinical context
Antiviral treatment for influenza works best when started early, and a fast answer also helps avoid unnecessary antibiotics. Fluorescent readers are widely used to make antigen tests more objective than reading a colored line by eye.
How OncoFirm will measure it
Built on the OncoFirm fluorescent platform
Part of a respiratory menu
Flu A/B is planned with COVID-19 and RSV so one reader covers the season’s most common viral tests.
A strip that checks itself
Every strip carries a fluorescent reference line of known brightness. Reading the test line against it corrects for reader and temperature drift, and the reader flags runs that did not flow correctly.
A traceable digital record
Each result is stored with the date, operator and lot, ready to share with a clinic record or laboratory system instead of being retyped by hand.
Where it's headed
Development roadmap
01
Feasibility
Antibody pairs, fluorescent conjugates and strip layout are selected and tested against the target.
02
Assay development
Strip, reagents and reader settings are optimized, and pilot lots are built.
03
Analytical validation
Precision, linearity, interference and lot-to-lot consistency are measured against reference methods.
04
Clinical evaluation and launch
Performance is evaluated with clinical samples. First release is planned for research use only, followed by regulatory submissions.
Related assays
Development status. This assay and the OncoFirm platform are in development. They have not been cleared or approved by the FDA and are not available for sale. First products are planned for research use only. Descriptions reflect design goals, not demonstrated performance.
Partner on this assay
We welcome research, clinical, manufacturing and distribution partners. Tell us how this assay fits your work.